Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer

• Main Authors: Charoentum C., Thongprasert S., Chewasakulyong B., Euathrongchit J., Sorraritchingchai S., Munprakan S.
• 格式: Article
• 語言: English
• 出版: 2014
• 在線閱讀: http://www.scopus.com/inward/record.url?eid=2-s2.0-37149053450&partnerID=40&md5=084d5a357dc486f92b8f7b40f356ff89; http://www.ncbi.nlm.nih.gov/pubmed/18181342; http://cmuir.cmu.ac.th/handle/6653943832/2115

Objective: To assess the activity and toxicity of cisplatin and irinotecan alternating with docetaxel in patients with advanced non-small cell lung cancer (NSCLC). Material and Method: Eligibility included chemo-naïve stage IIIB with malignant effusion and stage IV NSCLC patients with measurable dis...